NovaBridge Biosciences Investing Cash Flow
NovaBridge Biosciences (NBP) reported Investing Cash Flow of CNY 102.52 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-04-30
- NovaBridge Biosciences net cash provided by (used in) investing activities for the quarter ending 2020-12-31 was 54.48M CNY, a 29.55% decline year-over-year.
- NovaBridge Biosciences net cash provided by (used in) investing activities for the quarter ending 2019-12-31 was 77.33M CNY.
CNY
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | 102.52M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 458.38M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 499.34M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | -727.21M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | -381.38M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 54.48M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | -201.90M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | -256.38M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 77.33M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 212.46M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 135.13M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 9.50M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | -157.66M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $14.44M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $66.46M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $74.55M 6-K · filed 2022-11-10 | |||
| 2021-12-31 | -$114.11M 20-F · filed 2022-04-29 | |||
| 2020-12-31 | $6.82M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | -$30.94M 20-F · filed 2021-04-28 | ||
| 2020-09-30 | -$37.76M 6-K · filed 2021-02-05 | |||
| 2019-12-31 | $30.52M 20-F · filed 2020-04-29 |